DK0673932T3 - Sulfonamidocarbonylpyridin-2-carboxylsyreesteramider samt deres pyridin-N-oxider, fremgangsmåde til fremstilling deraf og a - Google Patents

Sulfonamidocarbonylpyridin-2-carboxylsyreesteramider samt deres pyridin-N-oxider, fremgangsmåde til fremstilling deraf og a

Info

Publication number
DK0673932T3
DK0673932T3 DK95103582T DK95103582T DK0673932T3 DK 0673932 T3 DK0673932 T3 DK 0673932T3 DK 95103582 T DK95103582 T DK 95103582T DK 95103582 T DK95103582 T DK 95103582T DK 0673932 T3 DK0673932 T3 DK 0673932T3
Authority
DK
Denmark
Prior art keywords
alkyl
bond
pyridine
opt
sic
Prior art date
Application number
DK95103582T
Other languages
Danish (da)
English (en)
Inventor
Klaus Dr Weidmann
Martin Dr Bickel
Volkmar Guenzler-Pukall
Original Assignee
Hoechst Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Ag filed Critical Hoechst Ag
Application granted granted Critical
Publication of DK0673932T3 publication Critical patent/DK0673932T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/81Amides; Imides
    • C07D213/82Amides; Imides in position 3
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/89Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members with hetero atoms directly attached to the ring nitrogen atom

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pulmonology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DK95103582T 1994-03-25 1995-03-13 Sulfonamidocarbonylpyridin-2-carboxylsyreesteramider samt deres pyridin-N-oxider, fremgangsmåde til fremstilling deraf og a DK0673932T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4410480A DE4410480A1 (de) 1994-03-25 1994-03-25 Sulfonamidocarbonylpyridin-2-carbonsäureesteramide sowie ihre Pyridin-N-oxide, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel

Publications (1)

Publication Number Publication Date
DK0673932T3 true DK0673932T3 (da) 2000-09-18

Family

ID=6513896

Family Applications (1)

Application Number Title Priority Date Filing Date
DK95103582T DK0673932T3 (da) 1994-03-25 1995-03-13 Sulfonamidocarbonylpyridin-2-carboxylsyreesteramider samt deres pyridin-N-oxider, fremgangsmåde til fremstilling deraf og a

Country Status (19)

Country Link
US (1) US5620996A (cs)
EP (1) EP0673932B1 (cs)
JP (1) JPH07278110A (cs)
KR (1) KR950032126A (cs)
AT (1) ATE193702T1 (cs)
AU (1) AU688450B2 (cs)
CA (1) CA2145475A1 (cs)
CZ (1) CZ289536B6 (cs)
DE (2) DE4410480A1 (cs)
DK (1) DK0673932T3 (cs)
ES (1) ES2146676T3 (cs)
FI (1) FI951387A7 (cs)
GR (1) GR3033706T3 (cs)
HU (1) HUT72598A (cs)
NO (1) NO304265B1 (cs)
NZ (1) NZ270784A (cs)
PL (1) PL180678B1 (cs)
PT (1) PT673932E (cs)
ZA (1) ZA952409B (cs)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE256113T1 (de) * 1996-03-21 2003-12-15 Lonza Ag Verfahren zur herstellung von arylamiden heteroaromatischer carbonsäuren
SK283920B6 (sk) 1996-03-28 2004-05-04 Lonza Ag Spôsob výroby arylamidov heteroaromatických karboxylových kyselín
PT806415E (pt) * 1996-05-09 2000-07-31 Lonza Ag Processo para a producao de amidas arilicas de acidos carboxilicos heteroaromaticos
CA2209392C (en) * 1996-07-23 2007-02-20 Yves Bessard Process for preparing pyridinecarboxylic esters
US6169183B1 (en) 1996-07-23 2001-01-02 Lonza, Ltd. Process for preparing pyridinecarboxylic esters
DE19742951A1 (de) * 1997-09-29 1999-04-15 Hoechst Schering Agrevo Gmbh Acylsulfamoylbenzoesäureamide, diese enthaltende nutzpflanzenschützende Mittel und Verfahren zu ihrer Herstellung
EP2295060B1 (en) 2001-12-06 2018-10-31 Fibrogen, Inc. Treatment or prevention of ischemic or hypoxic conditions
HU229475B1 (en) * 2001-12-06 2014-01-28 Fibrogen Methods of increasing endogenous erythropoietin (epo)
US8124582B2 (en) * 2002-12-06 2012-02-28 Fibrogen, Inc. Treatment of diabetes
US7618940B2 (en) * 2002-12-06 2009-11-17 Fibrogen, Inc. Fat regulation
US8614204B2 (en) 2003-06-06 2013-12-24 Fibrogen, Inc. Enhanced erythropoiesis and iron metabolism
EP1491527A1 (en) * 2003-06-25 2004-12-29 Bayer CropScience GmbH Process for preparing acylsulfamoylbenzamides
EP1919463B9 (en) 2005-06-15 2011-02-02 Fibrogen, Inc. Use of hif 1alfa modulators for treatment of cancer
KR100949980B1 (ko) * 2006-03-30 2010-03-29 엘지전자 주식회사 비디오 신호를 디코딩/인코딩하기 위한 방법 및 장치
DK2044005T3 (da) 2006-06-26 2011-01-24 Warner Chilcott Co Llc Prolylhydroxylasehæmmere og fremgangsmåder til anvendelse af disse
US8962530B2 (en) * 2007-06-27 2015-02-24 Regents Of The University Of Colorado Inflammatory bowel disease therapies
NO2686520T3 (cs) 2011-06-06 2018-03-17
SG11201509998WA (en) 2013-06-13 2016-01-28 Akebia Therapeutics Inc Compositions and methods for treating anemia
KR102381295B1 (ko) 2013-11-15 2022-03-31 아케비아 테라퓨틱스 인코포레이티드 {[5-(3-클로로페닐)-3-하이드록시피리딘-2-카보닐]아미노}아세트산의 고체형, 이의 조성물 및 용도
HK1247201A1 (zh) 2015-01-23 2018-09-21 阿克比治疗有限公司 2-(5-(3-氟苯基)-3-羥基吡啶甲醯胺)乙酸的固體形式、其組合物及用途
KR102866021B1 (ko) 2015-04-01 2025-09-30 아케비아 테라퓨틱스 인코포레이티드 빈혈 치료용 조성물 및 방법
CN105130888A (zh) * 2015-10-09 2015-12-09 中国药科大学 炔基吡啶类脯氨酰羟化酶抑制剂、其制备方法和医药用途
JP7440989B2 (ja) 2018-05-09 2024-02-29 アケビア セラピューティクス インコーポレイテッド 2-[5-(3-クロロフェニル)-3-ヒドロキシピリジン-2-カルボニル]アミノ]酢酸を調製するための方法
US11524939B2 (en) 2019-11-13 2022-12-13 Akebia Therapeutics, Inc. Solid forms of {[5-(3-chlorophenyl)-3-hydroxypyridine-2-carbonyl]amino} acetic acid

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0541042A1 (de) * 1991-11-05 1993-05-12 Hoechst Aktiengesellschaft Pyridin-2,4- und 2,5-dicarbonsäureamide und deren Derivate, Verfahren zu ihrer Herstellung sowie deren Verwendung als Arzneimittel
TW352384B (en) * 1992-03-24 1999-02-11 Hoechst Ag Sulfonamido- or sulfonamidocarbonylpyridine-2-carboxamides, process for their preparation and their use as pharmaceuticals

Also Published As

Publication number Publication date
FI951387L (fi) 1995-09-26
JPH07278110A (ja) 1995-10-24
NO951149D0 (no) 1995-03-24
ATE193702T1 (de) 2000-06-15
NO951149L (no) 1995-09-26
FI951387A7 (fi) 1995-09-26
AU1504395A (en) 1995-10-05
HK1011973A1 (en) 1999-07-23
ES2146676T3 (es) 2000-08-16
KR950032126A (ko) 1995-12-20
NO304265B1 (no) 1998-11-23
PT673932E (pt) 2000-09-29
HUT72598A (en) 1996-05-28
DE59508440D1 (de) 2000-07-13
FI951387A0 (fi) 1995-03-23
EP0673932A1 (de) 1995-09-27
CZ73495A3 (en) 1995-11-15
CZ289536B6 (cs) 2002-02-13
DE4410480A1 (de) 1995-09-28
PL180678B1 (pl) 2001-03-30
AU688450B2 (en) 1998-03-12
PL307847A1 (en) 1995-10-02
EP0673932B1 (de) 2000-06-07
ZA952409B (en) 1995-11-28
GR3033706T3 (en) 2000-10-31
US5620996A (en) 1997-04-15
NZ270784A (en) 1997-02-24
CA2145475A1 (en) 1995-09-26

Similar Documents

Publication Publication Date Title
DK0673932T3 (da) Sulfonamidocarbonylpyridin-2-carboxylsyreesteramider samt deres pyridin-N-oxider, fremgangsmåde til fremstilling deraf og a
DK0673931T3 (da) Sulfonamidocarbonylpyridin-2-carboxylsyreamider samt deres pyridin-N-oxider, fremgangsmåde til deres fremstilling og deres anvendelse som lægemiddel
FR2746397B1 (fr) Nouveaux derives silicies de l'acide salicylique a proprietes desquamantes
GR3034620T3 (en) Pyridine derivatives, process for their preparation and pharmaceutical compositions containing them
HUT45514A (en) Process for producing n-(morpholinyl- or tetrahydroazepinyl-alkyl)-benzamide derivatives and pharmaceutics comprising the same as active ingredient
MY131193A (en) 7-(2-aminoethyl)-benzothiazolones
HUT49349A (en) Process for producing substituted 6-phenyldihydro-3-/2h/-pyridazinone derivatives and pharmaceutical compositions comprising such compounds
IL91701A (en) Novel pyridyl- and pyrimidyl derivatives, process for their preparation and pharmaceutical compositions containing them
FR2771095B1 (fr) Nouveaux inhibiteurs de metalloproteases, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
HUT45255A (en) Process for producing furo/3,4-b/pyridine derivatives and pharmaceutical compositions comprising these compounds
GR3035644T3 (en) Aminated 6,7,8,9-tetrahydro-cyclopenta[a]naphtalene- and 2,3-dihydro-cyclopenta[e]indene-derivatives, process for their preparation and pharmaceutical compsitions containing them
DE3681432D1 (de) 4-thienyl-dihydropyridine, verfahren zur herstellung und ihre verwendung in arzneimitteln.
HUT60742A (en) Method for producing imidqzo-benzodiazepine-2-(1h)-one derivatives and pharmaceutical preparatives containing them